J3263 Injection, toripalimab-tpzi, 1 milligrams
J-Codes
Also known as: toripalimab, Tuoyi, PD-1 inhibitor
Toripalimab-tpzi (Tuoyi) 1 milligram injection is a programmed death receptor-1 inhibitor used for advanced melanoma and other cancers as immunotherapy.
Clinical Context
Indicated for unresectable or metastatic melanoma as a checkpoint immunotherapy. Blocks programmed death-1 pathway to enhance anti-tumor immunity. Requires monitoring for immune-related adverse events.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.